 | • レポートコード：QYR2104Z2728 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、医療用ナノテクノロジー（ナノ医療）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ナノメディシン、ナノ医療機器、ナノ診断、その他）、用途別市場規模（抗がん剤、CNS製品、抗感染症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・医療用ナノテクノロジー（ナノ医療）の市場動向 ・企業の競争状況、市場シェア ・医療用ナノテクノロジー（ナノ医療）の種類別市場規模（ナノメディシン、ナノ医療機器、ナノ診断、その他） ・医療用ナノテクノロジー（ナノ医療）の用途別市場規模（抗がん剤、CNS製品、抗感染症、その他） ・医療用ナノテクノロジー（ナノ医療）の北米市場規模2016-2027（アメリカ、カナダ） ・医療用ナノテクノロジー（ナノ医療）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・医療用ナノテクノロジー（ナノ医療）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・医療用ナノテクノロジー（ナノ医療）の中南米市場規模2016-2027（メキシコ、ブラジル） ・医療用ナノテクノロジー（ナノ医療）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Teva Pharmaceuticals、Abbott、UCB、Roche、Celgene、Sanofi、Merck & Co、Biogen、Stryker、Gilead Sciences、Pfizer、3M Company、Johnson & Johnson、SmitH& Nephew、Leadiant Biosciences、Kyowa Hakko Kirin、Takeda、Ipsen、Endo International） ・結論 |
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.
Market Analysis and Insights: Global Healthcare Nanotechnology (Nanomedicine) Market
The global Healthcare Nanotechnology (Nanomedicine) market size is projected to reach US$ 372870 million by 2026, from US$ 194920 million in 2019, at a CAGR of 9.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Healthcare Nanotechnology (Nanomedicine) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Healthcare Nanotechnology (Nanomedicine) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Healthcare Nanotechnology (Nanomedicine) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Healthcare Nanotechnology (Nanomedicine) market.
Global Healthcare Nanotechnology (Nanomedicine) Scope and Market Size
Healthcare Nanotechnology (Nanomedicine) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare Nanotechnology (Nanomedicine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
UCB
Roche
Pfizer
3M Company
Johnson & Johnson
SmitH& Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Perspective (2016-2027)
2.2 Healthcare Nanotechnology (Nanomedicine) Growth Trends by Regions
2.2.1 Healthcare Nanotechnology (Nanomedicine) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Healthcare Nanotechnology (Nanomedicine) Historic Market Share by Regions (2016-2021)
2.2.3 Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Regions (2022-2027)
2.3 Healthcare Nanotechnology (Nanomedicine) Industry Dynamic
2.3.1 Healthcare Nanotechnology (Nanomedicine) Market Trends
2.3.2 Healthcare Nanotechnology (Nanomedicine) Market Drivers
2.3.3 Healthcare Nanotechnology (Nanomedicine) Market Challenges
2.3.4 Healthcare Nanotechnology (Nanomedicine) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare Nanotechnology (Nanomedicine) Players by Revenue
3.1.1 Global Top Healthcare Nanotechnology (Nanomedicine) Players by Revenue (2016-2021)
3.1.2 Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Players (2016-2021)
3.2 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Healthcare Nanotechnology (Nanomedicine) Revenue
3.4 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio
3.4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare Nanotechnology (Nanomedicine) Revenue in 2020
3.5 Healthcare Nanotechnology (Nanomedicine) Key Players Head office and Area Served
3.6 Key Players Healthcare Nanotechnology (Nanomedicine) Product Solution and Service
3.7 Date of Enter into Healthcare Nanotechnology (Nanomedicine) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare Nanotechnology (Nanomedicine) Breakdown Data by Type
4.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Type (2016-2021)
4.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Type (2022-2027)
5 Healthcare Nanotechnology (Nanomedicine) Breakdown Data by Application
5.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Application (2016-2021)
5.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size (2016-2027)
6.2 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Type
6.2.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021)
6.2.2 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027)
6.2.3 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2027)
6.3 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Application
6.3.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021)
6.3.2 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027)
6.3.3 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2027)
6.4 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country
6.4.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2016-2021)
6.4.2 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size (2016-2027)
7.2 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type
7.2.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021)
7.2.2 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027)
7.2.3 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2027)
7.3 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application
7.3.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021)
7.3.2 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027)
7.3.3 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2027)
7.4 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country
7.4.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2016-2021)
7.4.2 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size (2016-2027)
8.2 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Type
8.2.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2027)
8.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Application
8.3.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2027)
8.4 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region
8.4.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size (2016-2027)
9.2 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Type
9.2.1 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021)
9.2.2 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027)
9.2.3 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2027)
9.3 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Application
9.3.1 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021)
9.3.2 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027)
9.3.3 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2027)
9.4 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country
9.4.1 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2016-2021)
9.4.2 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size (2016-2027)
10.2 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Type
10.2.1 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2027)
10.3 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Application
10.3.1 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2027)
10.4 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country
10.4.1 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Healthcare Nanotechnology (Nanomedicine) Introduction
11.1.4 Amgen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Details
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Introduction
11.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Healthcare Nanotechnology (Nanomedicine) Introduction
11.3.4 Abbott Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 UCB Business Overview
11.4.3 UCB Healthcare Nanotechnology (Nanomedicine) Introduction
11.4.4 UCB Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Healthcare Nanotechnology (Nanomedicine) Introduction
11.5.4 Roche Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Healthcare Nanotechnology (Nanomedicine) Introduction
11.6.4 Celgene Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.6.5 Celgene Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Healthcare Nanotechnology (Nanomedicine) Introduction
11.7.4 Sanofi Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Details
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Healthcare Nanotechnology (Nanomedicine) Introduction
11.8.4 Merck & Co Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.8.5 Merck & Co Recent Development
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Healthcare Nanotechnology (Nanomedicine) Introduction
11.9.4 Biogen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.9.5 Biogen Recent Development
11.10 Stryker
11.10.1 Stryker Company Details
11.10.2 Stryker Business Overview
11.10.3 Stryker Healthcare Nanotechnology (Nanomedicine) Introduction
11.10.4 Stryker Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.10.5 Stryker Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Introduction
11.11.4 Gilead Sciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.11.5 Gilead Sciences Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Healthcare Nanotechnology (Nanomedicine) Introduction
11.12.4 Pfizer Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.12.5 Pfizer Recent Development
11.13 3M Company
11.13.1 3M Company Company Details
11.13.2 3M Company Business Overview
11.13.3 3M Company Healthcare Nanotechnology (Nanomedicine) Introduction
11.13.4 3M Company Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.13.5 3M Company Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Introduction
11.14.4 Johnson & Johnson Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.14.5 Johnson & Johnson Recent Development
11.15 SmitH& Nephew
11.15.1 SmitH& Nephew Company Details
11.15.2 SmitH& Nephew Business Overview
11.15.3 SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Introduction
11.15.4 SmitH& Nephew Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.15.5 SmitH& Nephew Recent Development
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Details
11.16.2 Leadiant Biosciences Business Overview
11.16.3 Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Introduction
11.16.4 Leadiant Biosciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.16.5 Leadiant Biosciences Recent Development
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Details
11.17.2 Kyowa Hakko Kirin Business Overview
11.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Introduction
11.17.4 Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.17.5 Kyowa Hakko Kirin Recent Development
11.18 Takeda
11.18.1 Takeda Company Details
11.18.2 Takeda Business Overview
11.18.3 Takeda Healthcare Nanotechnology (Nanomedicine) Introduction
11.18.4 Takeda Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.18.5 Takeda Recent Development
11.18 Ipsen
.1 Ipsen Company Details
.2 Ipsen Business Overview
.3 Ipsen Healthcare Nanotechnology (Nanomedicine) Introduction
.4 Ipsen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
.5 Ipsen Recent Development
11.20 Endo International
11.20.1 Endo International Company Details
11.20.2 Endo International Business Overview
11.20.3 Endo International Healthcare Nanotechnology (Nanomedicine) Introduction
11.20.4 Endo International Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
11.20.5 Endo International Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nanomedicine
Table 3. Key Players of Nano Medical Devices
Table 4. Key Players of Nano Diagnosis
Table 5. Key Players of Other
Table 6. Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Regions (2016-2021)
Table 10. Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Regions (2022-2027)
Table 12. Healthcare Nanotechnology (Nanomedicine) Market Trends
Table 13. Healthcare Nanotechnology (Nanomedicine) Market Drivers
Table 14. Healthcare Nanotechnology (Nanomedicine) Market Challenges
Table 15. Healthcare Nanotechnology (Nanomedicine) Market Restraints
Table 16. Global Healthcare Nanotechnology (Nanomedicine) Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Players (2016-2021)
Table 18. Global Top Healthcare Nanotechnology (Nanomedicine) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare Nanotechnology (Nanomedicine) as of 2020)
Table 19. Ranking of Global Top Healthcare Nanotechnology (Nanomedicine) Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Healthcare Nanotechnology (Nanomedicine) Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Healthcare Nanotechnology (Nanomedicine) Product Solution and Service
Table 23. Date of Enter into Healthcare Nanotechnology (Nanomedicine) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Type (2016-2021)
Table 27. Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Healthcare Nanotechnology (Nanomedicine) Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Application (2016-2021)
Table 31. Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Healthcare Nanotechnology (Nanomedicine) Product
Table 66. Amgen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Teva Pharmaceuticals Company Details
Table 69. Teva Pharmaceuticals Business Overview
Table 70. Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Product
Table 71. Teva Pharmaceuticals Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 72. Teva Pharmaceuticals Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Healthcare Nanotechnology (Nanomedicine) Product
Table 76. Abbott Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. UCB Company Details
Table 79. UCB Business Overview
Table 80. UCB Healthcare Nanotechnology (Nanomedicine) Product
Table 81. UCB Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 82. UCB Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Healthcare Nanotechnology (Nanomedicine) Product
Table 86. Roche Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. Celgene Company Details
Table 89. Celgene Business Overview
Table 90. Celgene Healthcare Nanotechnology (Nanomedicine) Product
Table 91. Celgene Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 92. Celgene Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Healthcare Nanotechnology (Nanomedicine) Product
Table 96. Sanofi Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Merck & Co Company Details
Table 99. Merck & Co Business Overview
Table 100. Merck & Co Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 101. Merck & Co Recent Development
Table 102. Biogen Company Details
Table 103. Biogen Business Overview
Table 104. Biogen Healthcare Nanotechnology (Nanomedicine) Product
Table 105. Biogen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 106. Biogen Recent Development
Table 107. Stryker Company Details
Table 108. Stryker Business Overview
Table 109. Stryker Healthcare Nanotechnology (Nanomedicine) Product
Table 110. Stryker Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 111. Stryker Recent Development
Table 112. Gilead Sciences Company Details
Table 113. Gilead Sciences Business Overview
Table 114. Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Product
Table 115. Gilead Sciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 116. Gilead Sciences Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer Healthcare Nanotechnology (Nanomedicine) Product
Table 120. Pfizer Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 121. Pfizer Recent Development
Table 122. 3M Company Company Details
Table 123. 3M Company Business Overview
Table 124. 3M Company Healthcare Nanotechnology (Nanomedicine) Product
Table 125. 3M Company Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 126. 3M Company Recent Development
Table 127. Johnson & Johnson Company Details
Table 128. Johnson & Johnson Business Overview
Table 129. Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Product
Table 130. Johnson & Johnson Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 131. Johnson & Johnson Recent Development
Table 132. SmitH& Nephew Company Details
Table 133. SmitH& Nephew Business Overview
Table 134. SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Product
Table 135. SmitH& Nephew Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 136. SmitH& Nephew Recent Development
Table 137. Leadiant Biosciences Company Details
Table 138. Leadiant Biosciences Business Overview
Table 139. Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Product
Table 140. Leadiant Biosciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 141. Leadiant Biosciences Recent Development
Table 142. Kyowa Hakko Kirin Company Details
Table 143. Kyowa Hakko Kirin Business Overview
Table 144. Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Product
Table 145. Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 146. Kyowa Hakko Kirin Recent Development
Table 147. Takeda Company Details
Table 148. Takeda Business Overview
Table 149. Takeda Healthcare Nanotechnology (Nanomedicine) Product
Table 150. Takeda Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 151. Takeda Recent Development
Table 152. Ipsen Company Details
Table 153. Ipsen Business Overview
Table 154. Ipsen Healthcare Nanotechnology (Nanomedicine) Product
Table 155. Ipsen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 156. Ipsen Recent Development
Table 157. Endo International Company Details
Table 158. Endo International Business Overview
Table 159. Endo International Healthcare Nanotechnology (Nanomedicine) Product
Table 160. Endo International Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021) & (US$ Million)
Table 161. Endo International Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Type: 2020 VS 2027
Figure 2. Nanomedicine Features
Figure 3. Nano Medical Devices Features
Figure 4. Nano Diagnosis Features
Figure 5. Other Features
Figure 6. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Application: 2020 VS 2027
Figure 7. Anticancer Case Studies
Figure 8. CNS Product Case Studies
Figure 9. Anti-infective Case Studies
Figure 10. Other Case Studies
Figure 11. Healthcare Nanotechnology (Nanomedicine) Report Years Considered
Figure 12. Global Healthcare Nanotechnology (Nanomedicine) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Healthcare Nanotechnology (Nanomedicine) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Regions: 2020 VS 2027
Figure 15. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Regions (2022-2027)
Figure 16. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Players in 2020
Figure 17. Global Top Healthcare Nanotechnology (Nanomedicine) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare Nanotechnology (Nanomedicine) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Healthcare Nanotechnology (Nanomedicine) Revenue in 2020
Figure 19. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Type (2016-2021)
Figure 20. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Type (2022-2027)
Figure 21. North America Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2016-2027)
Figure 23. North America Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2016-2027)
Figure 24. North America Healthcare Nanotechnology (Nanomedicine) Market Share by Country (2016-2027)
Figure 25. United States Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2016-2027)
Figure 29. Europe Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2016-2027)
Figure 30. Europe Healthcare Nanotechnology (Nanomedicine) Market Share by Country (2016-2027)
Figure 31. Germany Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Share by Region (2016-2027)
Figure 41. China Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2016-2027)
Figure 49. Latin America Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2016-2027)
Figure 50. Latin America Healthcare Nanotechnology (Nanomedicine) Market Share by Country (2016-2027)
Figure 51. Mexico Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Share by Country (2016-2027)
Figure 57. Turkey Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 63. UCB Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 65. Celgene Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 67. Merck & Co Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 68. Biogen Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 69. Stryker Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 72. 3M Company Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 73. Johnson & Johnson Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 74. SmitH& Nephew Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 75. Leadiant Biosciences Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 76. Kyowa Hakko Kirin Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 77. Takeda Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 78. Ipsen Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 79. Endo International Revenue Growth Rate in Healthcare Nanotechnology (Nanomedicine) Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界のナノメディシン市場規模・現状・予測（2021年-2027年） Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. As per the WHO factsheet, …- 世界のナノテクノロジー市場規模・現状・予測（2021年-2027年） Nanotechnology applications are defined comprehensively as the creation and use of materials, devices and systems through the manipulation of matter at scales of less than 100 nanometers. In 2020, the global Nanotechnology market size will be US$ 1490.8 million and it is expected to reach US$ 2418.8…
- ナノ医療の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Nanomedicine from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to 2025. Th…
- 世界の医療機器用ナノヘルスケア技術市場規模・現状・予測（2021年-2027年） Nano healthcare technology can improve the disease diagnosis by carrying out its incorporation in monitoring devices, bioassay as well as imaging. The active implantable devices segment by product type is anticipated to carry on with its dominating streak during the 2018-2025 assessment period. Mark…
- 世界のがん治療におけるナノテクノロジー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nanotechnology in Cancer Treatment Market The global Nanotechnology in Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …